First Patient Receives Phase 1 Clinical Trial Dose of FS118

  The clinical trial for an antibody designed to treat advanced cancers has begun with the first dose of FS118. The treatment is supposed to target two immune checkpoint proteins. The study, based in the US, will be enrolling 51 patients who have been diagnosed with metastatic cancers. The patients have not previously responded to […]